Verve Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is May - April.

Millions JPY. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '25 Jul 31, 2025	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Market Capitalization	81,087	90,347	-	-	-
Enterprise Value	73,715	80,663	-	-	-
Last Close Price	690.00	772.00	-	-	-
PS Ratio	33.00	36.77	-	-	-
PB Ratio	13.24	14.75	-	-	-
P/TBV Ratio	14.99	16.70	-	-	-
EV/Sales Ratio	30.00	32.83	-	-	-
Debt / Equity Ratio	2.27	2.27	2.44	0.65	0.18
Asset Turnover	0.08	0.08	0.10	0.07	-
Quick Ratio	1.17	1.17	1.82	3.31	4.38
Current Ratio	1.28	1.28	2.00	3.50	4.46
Return on Equity (ROE)	-373.91%	-373.91%	-90.49%	-63.93%	-
Return on Assets (ROA)	-40.00%	-40.00%	-30.15%	-23.90%	-
Return on Capital (ROIC)	-60.67%	-60.67%	-38.69%	-29.32%	-
Earnings Yield	-26.58%	-23.85%	-	-	-
FCF Yield	-15.83%	-14.20%	-	-	-
Buyback Yield / Dilution	-26.06%	-26.06%	-8.60%	-11.93%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.